Innate Pharma SA Research And Development Expense

Quick Answer

Innate Pharma SA reported Research And Development Expense of $51.98 million for the year ending 2024.

  • Innate Pharma SA showed a decrease of -7.2% in Research And Development Expense from 2023 to 2024.
  • This data is from Innate Pharma SA's annual report (Form 10-K), filed with the SEC on April 30, 2025.
  • XBRL data for this metric is available from 2017 to 2024 (8 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 8 years of available data (2017 to 2024), Innate Pharma SA's Research And Development Expense has declined by 22.4%.
  • Historical annual values: Fiscal year 2024: $51.98 million | Fiscal year 2023: $56.02 million | Fiscal year 2022: $51.66 million | Fiscal year 2021: $47.00 million | Fiscal year 2020: $49.71 million | Fiscal year 2019: $62.90 million | Fiscal year 2018: $69.56 million | Fiscal year 2017: $67.00 million.
  • Data sourced from SEC EDGAR public filings as of June 20, 2026.

Last verified: